Close Menu

In the New York Times, Carl Zimmer discusses a tack being taken to fight viruses. Viruses, he says, evolve rapidly to escape the reaches of the immune system and to adjust to a new tissue that they have invaded, but mutate too much and the viruses suffer. "[Some scientists] hope to cure infections by forcing viruses to evolve their way to extinction," Zimmer writes.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

CNN reports that a US Food and Drug Administration document says Johnson & Johnson's SARS-CoV-2 vaccine meets the requirements to receive an Emergency Use Authorization.

According to BBC News, the global vaccine-sharing initiative has sent its first shipment, which arrived in Ghana this week.

Researchers in France are developing a new, fast test for SARS-CoV-2 that initial testing indicates may be highly accurate, the Guardian says.

In Cell this week: analysis of fitness patterns among SARS-CoV-2 isolates, single-cell transcriptome analysis of immune features in COVID-19, and more.